Liver, biliary & pancreatic cancer
12 articles shown
Does a Sudden Spike in a Tumor Marker Mean the Drug Has Stopped Working? Why One Number Is Not Enough, and How Imaging Confirms It
A sudden rise in a tumor marker during chemotherapy often triggers fear of resistance, but markers are only reference signals and one value cannot confirm that a drug has stopped working. This piece explains what drug resistance means, why marker levels fluctuate, and how CT or MRI imaging is used to assess treatment response.
When Inflammation Markers Are Normal but the Fever Won't Break — Understanding Tumor Fever and the Many Causes of Fever in Cancer Care
Explains why a fever can persist even when inflammation markers such as CRP and procalcitonin are low during cancer care. Covers non-infectious causes including tumor fever, drug fever, dehydration, and cholangitis, and how a fever diary and warning signs guide when to call the hospital.
When Surgery Couldn't Remove It All and Chemotherapy Begins — Understanding 'Residual Disease' and Post-Surgery Treatment in Bile Duct Cancer
A plain-language guide for families facing chemotherapy after bile duct cancer (cholangiocarcinoma) surgery that left residual disease. It explains what R1 and R2 resection mean, the difference between adjuvant and palliative chemotherapy, what to expect at a first chemo admission, and why new symptoms should be reported to the care team.
When a Pancreatic Tumor Wraps Around Major Blood Vessels — Understanding Resectability and 'Conversion Surgery' After Chemotherapy
When pancreatic cancer wraps around major blood vessels and immediate surgery is not possible, doctors grade resectability (resectable, borderline, locally advanced). This piece explains conversion surgery after neoadjuvant chemotherapy and why teams may advise a few more cycles before operating.
When Your Tumor Marker (CA19-9) Drops After the First Round of Chemo — Reading the Number Calmly Before You Celebrate or Worry
An explanation of what the CA19-9 tumor marker means in pancreatic and biliary cancers, why the trend matters more than a single value, that it can rise or fall for non-cancer reasons, and why it must be read alongside imaging and symptoms.
When Gallbladder Cancer Blocks the Bile Duct: Understanding Obstructive Jaundice and Biliary Drainage
How a blocked bile duct in gallbladder cancer causes obstructive jaundice, how biliary drainage with stents or PTBD restores bile flow, why the duodenum may also need a stent, warning signs to watch with a drain, and how to prepare for a second opinion.
When Your Chemo Dose Is Cut Because of Your Kidneys — Cisplatin and the Common Myth About a Salt-Free Diet
Cisplatin can stress the kidneys, so doses are often adjusted based on blood tests. The key to protecting the kidneys is adequate hydration rather than a salt-free diet, and diet or supplement changes should be guided by the care team.
When Your Belly Swells Up Every Evening After Pancreatic Surgery — Understanding and Easing Post-Operative Bloating
Common reasons abdominal bloating worsens after meals and in the evening following pancreatic surgery — slowed gut, gas, enzyme shortage, and altered anatomy — plus practical self-care and the warning signs that mean you should tell your care team.
Sudden Double Vision or Dizziness: Why Radiation May Come First When Cancer Reaches the Skull Base or Cranial Nerves
When advanced cancer reaches the skull base or cranial nerves, it can cause double vision, dizziness, and headaches. This plain-language guide explains how brain MRI and a spinal tap help locate the problem, why radiation and steroids are used for relief, and why radiation and chemotherapy are often sequenced rather than given together.
When Chemotherapy Stops Working: Understanding the Shift from First-Line to Second-Line Treatment in Pancreatic Cancer
Advanced pancreatic cancer is treated using sequential "lines" of chemotherapy. This article explains in plain language why resistance develops, how tumor markers like CA19-9 should be interpreted, and what factors guide the move from first-line to second-line treatment.
Stage 4 Liver Cancer with Bone Metastasis: Systemic Treatment Options to Consider
General information on systemic treatment options (combination immunotherapy and targeted therapy) and bone-protective care for stage 4 hepatocellular carcinoma with bone metastasis, including notes on treatment costs and support programs. Actual treatment should be decided with your physician based on liver function and overall condition.
Why Use 'Heat' Instead of a Knife on Small Liver Cancer — The Story of Radiofrequency Ablation (RFA)
Radiofrequency ablation (RFA) is a procedure that inserts a thin electrode into the tumor and uses radiofrequency energy to generate heat that burns away the cancer cells. Because the area that can be reliably burned at once is limited, it works best on small liver cancers — usually 3 cm or smaller and no more than three in number — and under these conditions it produces results comparable to surgery. Since the abdomen does not have to be opened wide, recovery is fast and it is advantageous for patients with weak liver function or frequent recurrence, but tumors attached to large blood vessels or nearby organs are difficult, so the medical team must decide based on location and size.